Drug General Information
Drug ID
D01EXL
Former ID
DIB001732
Drug Name
RNF43-721
Synonyms
RNF43-721/Montanide ISA51; Peptide vaccine (subcutaneous, colorectal cancer), Tokyo Women's Medical College
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 2 [544256]
Company
Vaccinogen
Target and Pathway
Target(s) RING finger protein 43 Target Info Modulator [544256]
References
Ref 544256Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer. Exp Ther Med. 2011 Jan-Feb; 2(1): 73-79.
Ref 544256Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer. Exp Ther Med. 2011 Jan-Feb; 2(1): 73-79.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.